loadpatents
name:-0.036747217178345
name:-0.025305986404419
name:-0.0017180442810059
NAKAJIMA; Motowo Patent Filings

NAKAJIMA; Motowo

Patent Applications and Registrations

Patent applications and USPTO patent grants for NAKAJIMA; Motowo.The latest application filed is for "enhancer of photodynamic effect in ala-pdt or ala-pdd".

Company Profile
1.27.35
  • NAKAJIMA; Motowo - Tokyo JP
  • Nakajima; Motowo - Minato-ku JP
  • Nakajima; Motowo - Hyogo Pref. JP
  • Nakajima; Motowo - Ashiya JP
  • Nakajima; Motowo - Ashiya-shi JP
  • Nakajima, Motowo - Hyogo JP
  • Nakajima; Motowo - Houston TX
  • Nakajima; Motowo - Kamagaya JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Enhancer Of Photodynamic Effect In Ala-pdt Or Ala-pdd
App 20200030275 - ISHIZUKA; Masahiro ;   et al.
2020-01-30
Agent for preventing and/or treating veisalgia
Grant 10,022,345 - Tanaka , et al. July 17, 2
2018-07-17
Prophylactic/therapeutic Agent For Virus Infections Which Comprises Ala Compound
App 20180125805 - TANAKA; Tohru ;   et al.
2018-05-10
Agent for improving normal development rate of fertilized eggs
Grant 9,962,350 - Tanaka , et al. May 8, 2
2018-05-08
Enhancer of survival of transplanted organ
Grant 9,937,138 - Rii , et al. April 10, 2
2018-04-10
Enhancer of survival of transplanted organ
Grant 9,901,558 - Rii , et al. February 27, 2
2018-02-27
Prophylactic and/or therapeutic agent for radiation damage
Grant 9,895,331 - Tanaka , et al. February 20, 2
2018-02-20
Organ Preservation Solution
App 20170202210 - TANAKA; Tohru ;   et al.
2017-07-20
Treatment agent and/or prophylactic agent for side effects of cancer drugs
Grant 9,707,196 - Tanaka , et al. July 18, 2
2017-07-18
Agent For Improving Normal Development Rate Of Fertilized Eggs
App 20170157074 - Tanaka; Tohru ;   et al.
2017-06-08
Anemia of cancer improving/prophylactic agent
Grant 9,539,225 - Tanaka , et al. January 10, 2
2017-01-10
Diagnostic agent for tumor
Grant 9,488,664 - Tanaka , et al. November 8, 2
2016-11-08
Prophylactic agent and/or therapeutic agent for sepsis
Grant 9,474,770 - Kinoshita , et al. October 25, 2
2016-10-25
Prophylactic agent for chronic kidney disease
Grant 9,475,755 - Tanaka , et al. October 25, 2
2016-10-25
Erythropoietin production-promoting agent
Grant 9,469,598 - Tanaka , et al. October 18, 2
2016-10-18
Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient
Grant 9,463,175 - Tanaka , et al. October 11, 2
2016-10-11
Frataxin Enhancer
App 20160271090 - CHIBAZAKURA; Taku ;   et al.
2016-09-22
Immune tolerance inducer
Grant 9,399,029 - Tanaka , et al. July 26, 2
2016-07-26
Enhancer Of Survival Of Transplanted Organ
App 20160206582 - RII; Ko ;   et al.
2016-07-21
Enhancer Of Survival Of Transplanted Organ
App 20160184250 - RII; Ko ;   et al.
2016-06-30
Prophylactic/therapeutic agent for influenza virus infection
Grant 9,351,949 - Tanaka , et al. May 31, 2
2016-05-31
Enhancer of survival of transplanted organ
Grant 9,314,443 - Rii , et al. April 19, 2
2016-04-19
Agent for Preventing and/or Treating Veisalgia
App 20160081957 - Tanaka; Tohru ;   et al.
2016-03-24
Antimalarial Drug Which Contains 5-Aminolevulinic Acid or Derivative Thereof as Active Ingredient
App 20150283102 - Tanaka; Tohru ;   et al.
2015-10-08
Photodynamic Diagnosis Apparatus Provided With Collimator
App 20150238085 - Inoue; Katsushi ;   et al.
2015-08-27
Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient
Grant 9,089,530 - Tanaka , et al. July 28, 2
2015-07-28
Prophylactic And/or Therapeutic Agent For Radiation Damage
App 20150190356 - Tanaka; Tohru ;   et al.
2015-07-09
Immune Tolerance Inducer
App 20150174090 - Tanaka; Tohru ;   et al.
2015-06-25
Prophylactic/therapeutic Agent For Influenza Virus Infection
App 20150164838 - Tanaka; Tohru ;   et al.
2015-06-18
Cancer heat therapy-enhancing agent
Grant 9,012,502 - Chibazakura , et al. April 21, 2
2015-04-21
Device For Determining Metastasis Of Cancer To Sentinel Lymph Node
App 20150038837 - Inoue; Katsushi ;   et al.
2015-02-05
Diagnostic Agent For Tumor
App 20150031013 - Tanaka; Tohru ;   et al.
2015-01-29
Agent for Preventing and/or Treating Veisalgia
App 20140343140 - Tanaka; Tohru ;   et al.
2014-11-20
Treatment Agent And/or Prophylactic Agent For Side Effects Of Cancer Drugs
App 20140302173 - Tanaka; Tohru ;   et al.
2014-10-09
Erythropoietin Production-promoting Agent
App 20140288172 - Tanaka; Tohru ;   et al.
2014-09-25
Anemia Of Cancer Improving/prophylactic Agent
App 20140288173 - Tanaka; Tohru ;   et al.
2014-09-25
Prophylactic Agent For Chronic Kidney Disease
App 20140256806 - Tanaka; Tohru ;   et al.
2014-09-11
Enhancer Of Survival Of Transplanted Organ
App 20140249217 - Rii; Ko ;   et al.
2014-09-04
Prophylactic Agent And/or Therapeutic Agent For Sepsis
App 20140186464 - Kinoshita; Kosaku ;   et al.
2014-07-03
Cancer Heat Therapy-enhancing Agent
App 20130158293 - Chibazakura; Taku ;   et al.
2013-06-20
Antimalarial Drug Which Contains 5-Aminolevulinic Acid or Derivative Thereof as Active Ingredient
App 20130108710 - Tanaka; Tohru ;   et al.
2013-05-02
Use of N-Phenyl-2-pyrimidineamine Derivatives Against Mast Cell-based Diseases Like Allergic Disorders
App 20120277246 - Heinrich; Michael ;   et al.
2012-11-01
Arylsulfonamido-substituted hydroxamic acid derivatives
Grant 8,034,810 - Breitenstein , et al. October 11, 2
2011-10-11
Use of N-Phenyl-2-pyrimidineamine Derivatives Against Mast Cell-based Diseases Like Allergic Disorders
App 20110201619 - Heinrich; Michael ;   et al.
2011-08-18
Use of N-Phenyl-2-Pyrimidineamine Derivatives Against Mast Cell-Based Diseases Like Allergic Disorders
App 20100144750 - Heinrich; Michael ;   et al.
2010-06-10
Arylsulfonamido-substituted hydroxamic acid derivatives
App 20080275127 - Breitenstein; Werner ;   et al.
2008-11-06
Arylsulfonamido-substituted hydroxamic acid derivatives
Grant 7,138,432 - Breitenstein , et al. November 21, 2
2006-11-21
Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer
App 20050232915 - Nakajima, Motowo ;   et al.
2005-10-20
Use of n-phenyl-2-pyrimidineamine derivativea against mast cell-based diseases like allergic disorders
App 20040157855 - Heinrich, Michael ;   et al.
2004-08-12
Human heparanase polypeptide and cDNA
App 20020115183 - Nakajima, Motowo ;   et al.
2002-08-22
Sulfonylamino acid and sulfonylamino hydroxamic acid derivatives
Grant 6,277,987 - Kukkola , et al. August 21, 2
2001-08-21
Solid-phase substrate containing modified heparin
Grant 5,332,812 - Nicolson , et al. July 26, 1
1994-07-26
Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness of metastatic profusion-II
Grant 5,262,403 - Nicolson , et al. November 16, 1
1993-11-16
Endoglycosidase assay
Grant 4,859,581 - Nicolson , et al. August 22, 1
1989-08-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed